Journal
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 93, Issue 2, Pages 115-115Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp-2021-327497
Keywords
frontotemporal dementia; primary progressive aphasia; randomised trials
Categories
Funding
- NIH [R01-NS109260, P01-AG066597, P30-AG10124, U19-AG062418]
- Penn Institute on Aging
Ask authors/readers for more resources
Therapeutic development for familial forms of FTLD is rapidly growing, and there is a need for adequate clinical tools to measure treatment effect, as addressed by Peakman et al.
There is a rapidly growing field of therapeutic development for familial forms of FTLD and Peakman et al address the important need for adequate clinical tools to measure treatment effect.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available